These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1516524)

  • 1. Relationship between pancreatic insulin content and serum C-peptide response in diabetic subjects.
    Tasaka Y; Matsumoto H; Inoue Y; Omori Y
    Diabetes Care; 1992 Jul; 15(7):937-8. PubMed ID: 1516524
    [No Abstract]   [Full Text] [Related]  

  • 2. A prospective study of glucose profiles, insulin antibody levels and beta cells secretory patterns in non-obese Ugandan diabetic subjects.
    Otim MA
    East Afr Med J; 1988 Jan; 65(1):8-15. PubMed ID: 3046922
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the etiology of "brittle diabetes". Relationship between diabetic instability and insulinogenic reserve.
    Shima K; Tanaka R; Morishita S; Tarui S; Kumahara Y
    Diabetes; 1977 Aug; 26(8):717-25. PubMed ID: 885295
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma C-peptide and serum insulin antibodies in diabetic patients receiving pancreatic transplants.
    Ostman J; Arner P; Groth CG; Gunnarsson R; Heding L; Lundgren G
    Diabetologia; 1980 Jul; 19(1):25-30. PubMed ID: 6993264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of serum C-peptide immunoreactivity by radioimmunoassay in insulin-dependent diabetics.
    Kumar MS; Schumacher OP; Deodhar SD
    Am J Clin Pathol; 1980 Jul; 74(1):78-82. PubMed ID: 6994486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The expediency of using B. I. Bleskin's method in treating diabetics].
    Mikhaĭlova EV; Lobanova AM; Romanovskaia GA; Mankeev SM
    Probl Endokrinol (Mosk); 1990; 36(3):46-7. PubMed ID: 2395835
    [No Abstract]   [Full Text] [Related]  

  • 7. [C-peptide and insulin in diabetics].
    Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):651-6. PubMed ID: 6819875
    [No Abstract]   [Full Text] [Related]  

  • 8. C-peptide, insulin and proinsulinlike components in diabetic and nondiabetic human pancreas.
    Tasaka Y; Takei M; Hirata Y
    Endocrinol Jpn; 1979 Jun; 26(3):313-8. PubMed ID: 225168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of circulating C-peptide in diabetes mellitus and hypoglycemic disorders.
    Rubenstein AH; Kuzuya H; Horwitz DL
    Arch Intern Med; 1977 May; 137(5):625-32. PubMed ID: 193451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous insulin needs. Relationship with duration of diabetes, C-peptidemia, insulin antibodies, and retinopathy.
    Haumont D; Dorchy H; Toussaint D; Despontin M
    Helv Paediatr Acta; 1982 May; 37(2):143-50. PubMed ID: 7047466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in mice.
    Flatt PR; Bailey CJ; Hampton SM; Swanston-Flatt SK; Marks V
    Horm Metab Res; 1987 Jan; 19(1):1-5. PubMed ID: 3549500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic control in diabetic patients. Effect of insulin-secretory reserve (measured by plasma C-peptide levels) and circulating insulin antibodies.
    Gonen B; Goldman J; Baldwin D; Goldberg RB; Ryan WG; Blix PM; Schanzlin D; Fritz KJ; Rubenstein AH
    Diabetes; 1979 Aug; 28(8):749-53. PubMed ID: 446933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamics of the glucagon and C-peptide content in Itsenko-Cushing disease].
    Arapova SD; Zavadskiĭ PS; Marova EI
    Sov Med; 1980; (2):42-7. PubMed ID: 6987746
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum adiponectin is associated with fasting serum C-peptide in non-obese diabetic patients.
    Furuta M; Tamai M; Hanabusa T; Yamamoto Y; Nanjo K; Sanke T
    Diabetes Res Clin Pract; 2006 Jun; 72(3):302-7. PubMed ID: 16442181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of anti-insulin antibodies of human serum in normal and diabetic subjects].
    Ghidoni A; Sorgato G; Sanesi E; Pozza G
    Acta Diabetol Lat; 1968; 5(2):173-86. PubMed ID: 5724363
    [No Abstract]   [Full Text] [Related]  

  • 16. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
    J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum uric acid and insulin secretion in diabetes mellitus.
    Sinagra D; Scarpitta AM; Bonaventura V; Greco D; Perrone P; Picone G; Brigandì M
    Riv Eur Sci Med Farmacol; 1996; 18(4):173-7. PubMed ID: 9177618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin antibodies in patients with type 2 diabetes mellitus].
    Martinka E; Straková J; Mokán M
    Vnitr Lek; 1998 Oct; 44(10):577-81. PubMed ID: 10422490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA antigens, hormonal profile and insulin antibodies in insulin-dependent diabetes mellitus with retinopathy].
    Vasiukova EA; Guliaeva ES; Kantsel'son LA; Kniazev IuA; Mikhaĭlova NA
    Klin Med (Mosk); 1981 Nov; 59(11):42-6. PubMed ID: 7033655
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin and proinsulin content of pancreases from diabetic and nondiabetic subjects.
    Rastogi GK; Sinha MK; Dash RJ
    Diabetes; 1973 Nov; 22(11):804-7. PubMed ID: 4795985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.